Item 2.02 Results of Operations and Financial Conditions.
On November 21, 2012, Arrhythmia Research Technology, Inc. (the "Company")
announced its financial results for the three months and the nine months ended
September 30, 2012. The full text of the press release issued in connection with
the announcement is furnished as Exhibit 99.01 to this Current Report on Form
8-K.
The information in this Form 8-K and Exhibit 99.01 attached hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.01 Press Release dated November 21, 2012.
Add
HRT to Portfolio
Set Alert
Email to a
Friend